MSA Team Works Toward Publications

March 16, 2020

MSA has submitted three manuscripts in high impact journals that report the results of pre-clinical experiments evaluating the pharmacokinetics (nasal absorption), pharmacodynamics (efficacy), and safety in support of Bryn Pharma’s goal to bring a cost-effective intranasal delivery system for patients with anaphylaxis to market.